Helicobacter Pylori Non-invasive Testing Market to Exceed USD 788.2 million by 2031, with a CAGR of 4.2%: Transparency Market Research, Inc
February 22, 2024 05:50 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global helicobacter pylori (H. Pylori) non-invasive testing market is estimated to surge...
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
February 21, 2024 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the...
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART
February 20, 2024 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced important developments in the...
Precision Diagnostics and Testing Technology Advancements: Innovation is Driving the Era of Value-based Care and Enabling Preventive and Personalized Health
February 19, 2024 04:26 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "Technology Advancements in Precision Diagnostics and Testing" report has been added to ResearchAndMarkets.com's offering. Precision diagnosis in...
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
February 13, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
HelixBind Named a Phase 2 Winner of the LymeX Diagnostics Prize by HHS and Steven & Alexandra Cohen Foundation
February 07, 2024 11:05 ET
|
HelixBind
HelixBind Named a Phase 2 Winner of the LymeX Diagnostics Prize by HHS and Steven & Alexandra Cohen Foundation
Cancer Profiling Research Report 2024: Market to Surge to $13.4 Billion Amid Advancements in Precision Medicine - Long-term Forecasts to 2028 and 2033
January 30, 2024 10:24 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cancer Profiling Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest in-depth cancer profiling market...
Global Exosome Diagnostics and Therapeutics Market 2024-2028 - Rising Demand for Early Cancer Detection Fuels Market Expansion
January 29, 2024 12:32 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Diagnostics and Therapeutics Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The latest market...
Asia-Pacific Multicancer Screening Market Analysis and Forecast, 2023-2032, Featuring Burning Rock DX, Genecast Biotechnology Co, and Konica Minolta (Ambry Genetics)
January 29, 2024 11:50 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Multicancer Screening Market - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.As of 2022,...
Global Autoimmune Disease Diagnostics Industry Forecasted at $17.9 Billion by 2028: Market Share Analysis by Technology, Indication, Gender, and Region
January 29, 2024 11:41 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Disease Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global autoimmune disease...